Anti-epileptics & anti- convulsants Flashcards
State the manifestation of epilepsy
- loss/ disturbance of consciousness
- characteristic body movement
State the pathophysiology of epilepsy
excitation: glutamate
inhibition: GABA
-> imbalance => prone to excitation
Differentiate absence and non absence type epilepsy
absence type:
- focus in thalamus
- neurons fire abnormally and mediated by Ca2+ T type channels (slower)
non absence type:
- excessive neuronal discharge from rapid AP firing mediated by Na+ channels
Phenytoin MOA
- prolongs inactivated state of Na+ channel -> longer refractory period
- depress presynaptic glutamate release
- facilitate GABA release (reduce Ca2+ release)
State use of phenytoin
- used for status epilepticus when foephenytoin not available
- used to be for: GTCS and partial seizure
- now only when better drugs cannot be used
State phenytoin relationship with CYP
- potent inducer of CYP2C8/9, CYP3A4/5
- competitively inhibits CYP2C9/19
State phenytoin metabolism due to interaction
- phenobarbitone inhibts
- carbamazepine induce
- valproate decrease
State how phenytoin affects other drugs
- inhibits warfarin metabolism
- induce enzyme
-> degrade steroids
-> failure of oral contraceptive
Carbamazepine MOA
- actions resemble phenytoin:
1. inhibit high frequency neuronal discharge
2. decrease presynaptic transmitter release
- lithium like effect in mania and bipolar
Use of carbamazepine
- simple and complex partial seizure
- GTCS
(same as phenobarbitone)
-> can exacerbate myoclonic and absence seizures
State carbamazepine interaction
- enzyme inducer
-> reduce efficacy of haloperidol/ oral contraceptive/ lamotrigine/ valproate/ topiramate - its own metabolism
-> induced by phenobarbitone, phenytoin
Ethosuximide MOA and use
- selectively suppress T type Ca2+ channels
- selective action on absence seizures
Ethosuximide side effects
- GI intolerance
- headache
- inability to concentrate
Phenobarbitone MOA
enhance GABAa receptor mediated synaptic inhibition
State phenobarbitone interaction
- CYP450 inducer
- valproate raise phenobarbitone level when given concurrently
Adverse effects of phenobarbitone
- sedation
- hepatotoxicity
- resp/ CV depression -> overdose can be fatal
- behavioural abnormalities
State use of phenobarbitone
- effective in GTCS, simple partial, complex partial seizures (same as carbamazepine)
- now infrequently used due to behavioural side effects
- not effective in absence and atonic seizure